Literature DB >> 10867296

Continuation of high-risk behavior by HIV-positive drug users. Treatment implications.

S K Avants1, L A Warburton, K A Hawkins, A Margolin.   

Abstract

Drug users who are positive for the human immunodeficiency virus (HIV) represent a major vector of HIV transmission, yet relatively little is known about their continued drug- and sex-related HIV-risk behavior, which may impede the development of effective risk-reduction interventions. In this study, 50 HIV-seropositive injection drug users entering methadone maintenance treatment completed a comprehensive risk assessment battery, including self-report of HIV-risk behavior since learning HIV serostatus, and measures of risk-reduction information, motivation, and behavioral skills. We found that a disconcertingly high proportion of patients (66%) reported having engaged in HIV-risk behavior since learning their HIV-seropositive status. Level of HIV-related knowledge did not predict high-risk behavior. Drug-related risk behavior was predicted by psychiatric severity and poor behavioral skills. Sex-related risk was predicted by low levels of motivation and poor behavioral skills. Implications of these findings for treatment are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10867296     DOI: 10.1016/s0740-5472(99)00092-6

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  31 in total

1.  Predictors of sexual transmission risk behaviors among HIV-positive young men.

Authors:  J A Stein; M-J Rotheram-Borus; D Swendeman; N G Milburn
Journal:  AIDS Care       Date:  2005-05

2.  Optimizing a community-friendly HIV risk reduction intervention for injection drug users in treatment: a structural equation modeling approach.

Authors:  Michael M Copenhaver; I-Ching Lee
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

3.  HIV-transmission-related risk behavior in HIV+ African American men: Exploring biological, psychological, cognitive, and social factors.

Authors:  Alyssa Arentoft; Kathleen Van Dyk; April D Thames; Nicholas S Thaler; Philip Sayegh; Charles H Hinkin
Journal:  J HIV AIDS Soc Serv       Date:  2016-06-28

4.  The influence of the perceived consequences of refusing to share injection equipment among injection drug users: balancing competing risks.

Authors:  Karla D Wagner; Stephen E Lankenau; Lawrence A Palinkas; Jean L Richardson; Chih-Ping Chou; Jennifer B Unger
Journal:  Addict Behav       Date:  2011-03-25       Impact factor: 3.913

5.  Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus.

Authors:  David W Purcell; Yuko Mizuno; Lisa R Metsch; Richard Garfein; Karin Tobin; Kelly Knight; Mary H Latka
Journal:  J Urban Health       Date:  2006-07       Impact factor: 3.671

6.  Sexual activity in HIV-positive African American crack cocaine smokers.

Authors:  Sandra C Timpson; Mark L Williams; Anne M Bowen; John S Atkinson; Michael W Ross
Journal:  Arch Sex Behav       Date:  2010-07-14

7.  Iowa Gambling Task performance and emotional distress interact to predict risky sexual behavior in individuals with dual substance and HIV diagnoses.

Authors:  Margaret C Wardle; Raul Gonzalez; Antoine Bechara; Eileen M Martin-Thormeyer
Journal:  J Clin Exp Neuropsychol       Date:  2010-05-17       Impact factor: 2.475

8.  In-home mental health treatment for individuals with HIV.

Authors:  Susan S Reif; Brian W Pence; Sara LeGrand; Elena S Wilson; Marvin Swartz; Terry Ellington; Kathryn Whetten
Journal:  AIDS Patient Care STDS       Date:  2012-10-10       Impact factor: 5.078

9.  Knowledge of HIV Transmission and Associated Factors among HIV-Positive and HIV-Negative Patients in Rural Kenya.

Authors:  Steven Y Hong; Daria Thompson; Christine Wanke; Gloria Omosa; Michael R Jordan; Alice M Tang; Shem Patta; Ben Mwero; Innocent Mjomba; Mkaya Mwamburi
Journal:  J AIDS Clin Res       Date:  2012-09-24

10.  The context of HIV risk behaviours among HIV-positive injection drug users in Viet Nam: moving toward effective harm reduction.

Authors:  Duong Cong Thanh; Karen Marie Moland; Knut Fylkesnes
Journal:  BMC Public Health       Date:  2009-04-06       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.